本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Protalix BioTherapeutics Inc

1.53
+0.05003.38%
盘后1.550.0231+1.51%18:30 EDT
成交量:59.57万
成交额:90.07万
市值:1.22亿
市盈率:31.77
高:1.53
开:1.48
低:1.46
收:1.48
数据加载中...
2021/06/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/02

重要事件披露

8-K - Current report
2021/05/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/14

重要事件披露

8-K - Current report
2021/04/30

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/28

重要事件披露

8-K - Current report
2021/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/30

重要事件披露

8-K - Current report
2021/02/23

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/30

重要事件披露

8-K - Current report
2020/11/24

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/29

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/29

重要事件披露

8-K - Current report